Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)

Gynecological Endocrinology

Volumn 29, Issue 5, 2013, Pages 470-473

  Arefi, Soheila ^a   Mottaghi, Sayeh ^b   Sharifi, Ali M ^b,c  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Insulin resistance; Polycystic ovarian syndrome; Renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANGIOTENSIN II; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; PEPTIDYL-DIPEPTIDASE A; POLYCYSTIC OVARY SYNDROME; RENIN; RENIN-ANGIOTENSIN SYSTEM; UP-REGULATION; YOUNG ADULT;

EID: 84875825529     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.769513     Document Type: Article

References (18)

1. Azziz R, Marin C, Hoq L, et al. Healthcare-related economic burden of the polycystic ovary syndrome (PCOS) during the reproductive lifespan. J Clin Endocrinol Metab 2005;90:4650-8. (Pubitemid 41159355)
2. Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72-84.
3. Cibula D, Cifkova R, Fanta M, et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of polycystic ovary syndrome. Hum Reprod 2000;15:785-9. (Pubitemid 30192723)
4. Liu Z. The renin-angiotensin system and insulin resistance. Curr Diab Rep 2007;7:34-42. (Pubitemid 46344187)
5. Leung PS. Intrinsic angiotensin-generating system: its tissue specific functions and clinical implications. Panminerva Med 2002;44:93-7. (Pubitemid 41315644)
6. Wu X, Lu K, Su Y. Renin-angiotensin system: involvement in polycystic ovarian syndrome. Zhonghua Fu Chan Ke Za Zhi 1997;32:428-31.
7. Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensingenerating system and dose-dependent inhibition of glucosestimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004;47:240-8. (Pubitemid 38315360)
8. Bernini GP, Bela S, Cionini R, et al. Aldosterone and renin plasma levels in young patients with polycystic ovary syndrome. Endocrine Abstracts 2006;11:P692.
9. Uncu G, So?zer MC, Develiog lu O, Cengiz C. 2The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS. Gynecol Endocrinol 2002;16:447-52. (Pubitemid 36140299)
10. Yanes LL, Davis D, Romero DG, Reckelhoff JF. Activation of Angiotensin II mediated hypertension in a rat model of polycystic ovary syndrome. FASEB J 2010;24 (Meeting abstract supplement) 1041.14.
11. Bednarek-Tupikowska G, Zdrojewicz Z. Activity of the enzyme converting angiotensin I to angiotensin II (ACE) in patients with polycystic ovary syndrome. Endokrynol Pol 2003;44:169-74.
12. Sharifi AM, Darabi R, Akbarloo N, et al. Investigation of circulatory and tissue ACE activity during development of lead-induced hypertension. Toxicol Lett 2004;153:233-8. (Pubitemid 39296980)
13. Sharifi AM, Akbarloo N, Darabi R, Larijani B. Study of correlation between elevation of blood pressure and tissue ACE activity during development of hypertension in 1K1C rats. Vasc Pharmacol 2004;41:15-20. (Pubitemid 38595541)
14. Sharifi AM, Akbarloo N, Heshmatian B, Ziai A. Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension. Pharmacol Res 2003;47:201-9. (Pubitemid 36259922)
15. Sharifi AM, Akbarloo N, Darabi R. Investigation of local ACE activity and structural alterations during development of L-NAMEinduced hypertension. Pharmacol Res 2005;52:438-44. (Pubitemid 41531164)
16. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454-60. (Pubitemid 40615820)
17. Lu XE, Huang HF, Li MG, et al. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles. J Zhejiang Univ Sci B 2005;6: 897-902.
18. Ainslie GM, Benatar SR. Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy. Q J Med 1985;55:253-70. (Pubitemid 15028241)